Biotechnology and Health Care

Currently Funded Centers

Award No. 2133504

Duke University in partnership with North Carolina Agricultural and Technical State University, North Carolina State University, the University of North Carolina at Chapel Hill, and the University of North Carolina at Charlotte

PreMiEr's mission is to c

reate microbiome technologies that address challenges at the interface of human health and the built environment, promoting the proliferation of beneficial microorganisms and preventing colonization by infectious agents

Award No. 1941543


University of Minnesota in partnership with Massachusetts General Hospital, the University of California, Berkeley, and the University of California, Riverside

ATP-Bio aims to develop and deploy breakthrough bioengineering technology to “stop biological time” through development and translation of new techniques for biopreservation. These technologies will preserve a wide range of biological systems in order to advance research and technological innovation: cells, tissues, organs, and whole organisms.

Award No. 1648451


Texas A&M University in partnership with University of California at Los Angeles, Rice University, and Florida International University.

The vision of the NSF-ERC on Precise Advanced Technologies and Health Systems for Underserved Populations (PATHS-UP) is to change the paradigm for the health of underserved populations by developing revolutionary, cost-effective technologies and systems at the point-of-care (POC).

Award No. 1647837


Boston University in partnership with University of Michigan and Florida International University.

CELL-MET aims to transform cardiovascular care by combining breakthroughs in nanotechnology and manufacturing with tissue engineering and regenerative medicine, while also developing areas of expertise in education, diversity, administration, and outreach.

Graduated Centers (Self-sustaining)

Nanosystems ERC for Advanced Self-Powered Systems of Integrated Sensors and Technologies

The vision of ASSIST is to harness nanotechnology to improve global health by enabling correlation between personal health and personal environment and by empowering patients and doctors to manage wellness and improve quality of life

Bioengineering Educational Technologies

VaNTH is engaged in efforts to transform bioengineering education by developing, implementing, and assessing educational processes, materials, and learning technologies.

Center for Biofilm Engineering

Inspired by fundamental discoveries about microbial communities on surfaces, the CBE develops solutions to industrially relevant biofilm problems and engineers uses for beneficial microbial biofilms

Center for Computer-Integrated Surgical Systems and Technology

Develop surgical systems that integrate novel computer and human/machine interface technologies that will revolutionize surgical procedures, extending the surgeon's abilities to achieve better outcomes at lower costs

Regenerative Engineering and Medicine Center

Integrate engineering technologies, biological discoveries, and clinical expertise and infrastructure so as to fundamentally transform the treatment of human diseases and injuries through the development and translation of new technologies that enhance the body’s ability to heal itself

University of Washington Engineered Biomaterials ERC

UWEB brings together a cross-disciplinary team of scientists, biologists, engineers, researchers and physicians, as well as industry leaders, to exploit specific biological mechanisms in the development of medical innovations.

Center for Neurotechnology

The CNT will seek to identify the engineering principles of neural movement control and sensory processing to enable a new generation of robust, adaptive, closed loop, sensorimotor devices that interact with human nervous systems.

Biomimetic MicroElectronic Systems ERC

BMES is developing transformative neural prostheses using novel biomimetic microelectronic systems based on fundamental principles of biology and engineering.

ERC for Revolutionizing Metallic Biomaterials

RMB is developing the fundamental knowledge and technology needed to advance biocompatible and biodegradable metal-based, implantable systems with feedback control for reconstruction and regeneration.